PROQR THERAPEUTICS N.V. news, videos and press releases - Page 3
For more news please use our advanced search feature.
PROQR THERAPEUTICS N.V. - More news...
PROQR THERAPEUTICS N.V. - More news...
- ProQR to Present at Upcoming JMP Securities Life Sciences Conference
- ProQR Announces First Quarter 2021 Operating and Financial Results
- ProQR Therapeutics and Yarrow Biotechnology, an RTW Investments, LP Incubated Company, Announce Exclusive Worldwide License and Discovery Collaboration for Undisclosed Target
- ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021
- ProQR Announces Participation in Upcoming Kempen Life Sciences Conference
- ProQR Announces Annual Meeting of Shareholders
- ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10
- ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
- ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021
- ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
- ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
- ProQR Therapeutics N.V. - PRQR Stock Chart Technical Analysis for 03-25-2021
- ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
- ProQR to Present Results from Phase 1/2 Trial of QR-421a for Usher Syndrome
- ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference
- ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results
- ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
- ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10
- ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference
- ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference
- ProQR Announces Third Quarter 2020 Operating and Financial Results
- ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO)
- ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer
- ProQR Announces Virtual Presentations at Scientific Conferences
- ProQR to Participate in Upcoming Investor Conferences
- ProQR Announces Second Quarter 2020 Operating and Financial Results
- ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy
- ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
- ProQR Announces Expert Perspectives Call on LCA10 and Sepofarsen
- ProQR Announces Expert Perspectives Conference Call Series